These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37931386)

  • 1. Molecular detection of pre-ribosomal RNAs of Mycobacterium bovis bacille Calmette-Guérin and Mycobacterium tuberculosis to enhance pre-clinical tuberculosis drug and vaccine development.
    Chang M; Venkatasubramanian S; Barrett H; Urdahl KB; Weigel KM; Cangelosi GA; Shah JA; Saha A; Feng L; Adams KN; Sherman DR; Smith N; Seshadri C; Kublin JG; Murphy SC
    Diagn Microbiol Infect Dis; 2024 Jan; 108(1):116106. PubMed ID: 37931386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-Generation Vaccines Based on Bacille Calmette-Guérin.
    Nieuwenhuizen NE; Kaufmann SHE
    Front Immunol; 2018; 9():121. PubMed ID: 29459859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?
    Moliva JI; Turner J; Torrelles JB
    Vaccine; 2015 Sep; 33(39):5035-41. PubMed ID: 26319069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the protective efficacy of bacille calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis.
    Williams A; Davies A; Marsh PD; Chambers MA; Hewinson RG
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S299-301. PubMed ID: 10875804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of bacille Calmette-Guerin (BCG) and Mycobacterium tuberculosis in tissue biopsy specimens of children vaccinated with BCG.
    Monajemzadeh M; Shahsiah R; Zarei A; Alamooti AA; Mahjoub F; Mamishi S; Khotai G; Pazira R; Eram N
    Am J Clin Pathol; 2010 Jan; 133(1):102-6. PubMed ID: 20023264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative transcriptomics reveals common and strain-specific responses of human macrophages to infection with Mycobacterium tuberculosis and Mycobacterium bovis BCG.
    Li P; Li Y; Wang CC; Xia LG
    Microb Pathog; 2024 Apr; 189():106593. PubMed ID: 38387847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
    Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and vaccine potential of clinical isolate
    Kim H; Shin SJ
    Microbiol Spectr; 2024 Aug; 12(8):e0081924. PubMed ID: 38980025
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative Proteomic Profiling of
    Kasempimolporn S; Premchaiporn P; Thaveekarn W; Boonchang S; Sitprija V
    J Glob Infect Dis; 2018; 10(4):196-200. PubMed ID: 30581260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis.
    Chen YY; Lin CW; Huang WF; Chang JR; Su IJ; Hsu CH; Cheng HY; Hsu SC; Dou HY
    J Microbiol Immunol Infect; 2017 Feb; 50(1):90-96. PubMed ID: 25732698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and safety of vaccines against tuberculosis in the relation to genetic variability of Mycobacterium bovis BCG strains].
    Prygiel M; Janaszek-Seydlitz W; Bucholc B
    Przegl Epidemiol; 2011; 65(4):621-8. PubMed ID: 22390050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and protective efficacy of recombinant Bacille Calmette-Guerin strains expressing mycobacterium antigens Ag85A, CFP10, ESAT-6, GM-CSF and IL-12p70.
    Dai FY; Wang JF; Gong XL; Bao L
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-8. PubMed ID: 28301284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant BCG as a vaccine vehicle to protect against tuberculosis.
    Triccas JA
    Bioeng Bugs; 2010; 1(2):110-5. PubMed ID: 21326936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary pyridoxine controls efficacy of vitamin B6-auxotrophic tuberculosis vaccine bacillus Calmette-Guérin ΔureC::hly Δpdx1 in mice.
    Gengenbacher M; Vogelzang A; Schuerer S; Lazar D; Kaiser P; Kaufmann SH
    mBio; 2014 Jun; 5(3):e01262-14. PubMed ID: 24895310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology.
    Abebe F
    Clin Exp Immunol; 2012 Sep; 169(3):213-9. PubMed ID: 22861360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and cross-reactivity against Mycobacterium tuberculosis of proteoliposomes derived from Mycobacterium bovis BCG.
    Reyes F; Tirado Y; Puig A; Borrero R; Reyes G; Fernández S; Pérez JL; Kadir R; Zayas C; Norazmi MN; Sarmiento ME; Acosta A
    BMC Immunol; 2013; 14 Suppl 1(Suppl 1):S7. PubMed ID: 23458692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteremia due to Mycobacterium tuberculosis or M. bovis, Bacille Calmette-Guérin (BCG) among HIV- positive children and adults in Zambia.
    Waddell RD; Lishimpi K; von Reyn CF; Chintu C; Baboo KS; Kreiswirth B; Talbot EA; Karagas MR;
    AIDS; 2001 Jan; 15(1):55-60. PubMed ID: 11192868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium tuberculosis H37Rv: Delta RD1 is more virulent than M. bovis bacille Calmette-Guérin in long-term murine infection.
    Sherman DR; Guinn KM; Hickey MJ; Mathur SK; Zakel KL; Smith S
    J Infect Dis; 2004 Jul; 190(1):123-6. PubMed ID: 15195251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Multiplex Real-Time PCR Assay for Mycobacterium bovis BCG and Validation in a Clinical Laboratory.
    Duffy SC; Venkatesan M; Chothe S; Poojary I; Verghese VP; Kapur V; Behr MA; Michael JS
    Microbiol Spectr; 2021 Oct; 9(2):e0109821. PubMed ID: 34494864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.